49 related articles for article (PubMed ID: 1820874)
21. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
Darwish M; Chang S; Hellriegel ET
Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the pharmacokinetics of ticlopidine between administration of a combined fixed-dose tablet formulation of ticlopidine 250 mg/ginkgo extract 80 mg, and concomitant administration of ticlopidine 250-mg and ginkgo extract 80-mg tablets: an open-label, two-treatment, single-dose, randomized-sequence crossover study in healthy Korean male volunteers.
Kim TE; Kim BH; Kim J; Kim KP; Yi S; Shin HS; Lee YO; Lee KH; Shin SG; Jang IJ; Yu KS
Clin Ther; 2009 Oct; 31(10):2249-57. PubMed ID: 19922896
[TBL] [Abstract][Full Text] [Related]
23. An open study of tolerability and pharmacokinetics of raclopride extended release capsules in psychiatric patients: a Canadian study.
Gendron A; Sirois G; Nair NP; Bloom D; Movin-Osswald G; Uppfeldt G
J Psychiatry Neurosci; 1995 Jul; 20(4):287-96. PubMed ID: 7647082
[TBL] [Abstract][Full Text] [Related]
24. Bioequivalence evaluation of two different oral formulations of loperamide (Diarex Lactab vs Imodium capsules).
Doser K; Meyer B; Nitsche V; Binkert-Graber P
Int J Clin Pharmacol Ther; 1995 Aug; 33(8):431-6. PubMed ID: 8556221
[TBL] [Abstract][Full Text] [Related]
25. Preliminary pharmacokinetics of a new pyridopyrimidine derivative.
Pérez MJ; Roch MJ; Ochoa MC
Arzneimittelforschung; 1991 Jun; 41(6):640-4. PubMed ID: 1930354
[TBL] [Abstract][Full Text] [Related]
26. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
Smith WB; Dowell JA; Pratt RD
Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
[TBL] [Abstract][Full Text] [Related]
28. Bioavailability and pharmacokinetic comparison between generic and branded azithromycin capsule: a randomized, double-blind, 2-way crossover in healthy male Thai volunteers.
Boonleang J; Panrat K; Tantana C; Krittathanmakul S; Jintapakorn W
Clin Ther; 2007 Apr; 29(4):703-10. PubMed ID: 17617293
[TBL] [Abstract][Full Text] [Related]
29. Determination of the optimal dose of the antihypertensive drug cicletanine hydrochloride in man.
Guinot P; Jewitt-Harris J; Tarrade T
Arzneimittelforschung; 1989 Jan; 39(1):86-9. PubMed ID: 2655611
[TBL] [Abstract][Full Text] [Related]
30. Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up study.
Vollmer T; Blight AR; Henney HR
Clin Ther; 2009 Oct; 31(10):2215-23. PubMed ID: 19922892
[TBL] [Abstract][Full Text] [Related]
31. Determination of cicletanine enantiomers in plasma by high-performance capillary electrophoresis.
Pruñonosa J; Obach R; Diez-Cascón A; Gouesclou L
J Chromatogr; 1992 Feb; 574(1):127-33. PubMed ID: 1629275
[TBL] [Abstract][Full Text] [Related]
32. Comparison of high-performance liquid chromatography and high-performance capillary electrophoresis for the determination of cicletanine in plasma.
Pruñonosa J; Obach R; Diez-Cascón A; Gouesclou L
J Chromatogr; 1992 Oct; 581(2):219-26. PubMed ID: 1452612
[TBL] [Abstract][Full Text] [Related]
33. A drug interaction study between cicletanine and tolbutamide in healthy volunteers.
Bayés MC; Barbanoj MJ; Vallès J; Torrent J; Obach R; Jané F
Eur J Clin Pharmacol; 1996; 50(5):381-4. PubMed ID: 8839660
[TBL] [Abstract][Full Text] [Related]
34. Stereoselective biotransformation of cicletanine in cultured rat and human hepatocytes.
Menard C; Lamiable D; Vistelle R; Morin E; Ratanasavanh D
Pharmacol Res; 2000 Jul; 42(1):87-92. PubMed ID: 10860640
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of moxonidine after single and repeated daily doses in healthy volunteers.
Trenk D; Wagner F; Jähnchen E; Plänitz V
J Clin Pharmacol; 1987 Dec; 27(12):988-93. PubMed ID: 3437071
[TBL] [Abstract][Full Text] [Related]
36. High-performance liquid chromatographic assay for the simultaneous measurement of two spironolactone analogues, 17 beta-hydroxy-3-oxo-17-pregn-4-ene-21-carboxylic acid-gamma-lactone 7 alpha-methyl ethyl ester and its 6 beta-hydroxylated derivative.
Jackson LS; Stafford JE
J Chromatogr; 1988 Jul; 428(2):377-82. PubMed ID: 3215941
[No Abstract] [Full Text] [Related]
37. Multiple dose pharmacokinetic study of cicletanine in healthy volunteers.
Peraire C; Torrent J; Pruñonosa J; Azcona O; Nomen M; Obach R
Eur J Drug Metab Pharmacokinet; 1991; Spec No 3():173-7. PubMed ID: 1820874
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetic study of cicletanine in healthy volunteers.
Pruñonosa J; Peraire C; Torrent J; Obach R
Int J Clin Pharmacol Ther Toxicol; 1992 Aug; 30(8):265-70. PubMed ID: 1526688
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics of cicletanine in patients with impaired renal function.
Jungers P
Drugs Exp Clin Res; 1988; 14(2-3):189-94. PubMed ID: 3416723
[TBL] [Abstract][Full Text] [Related]
40. Clinical pharmacokinetics of cicletanine hydrochloride.
Fredj G
Drugs Exp Clin Res; 1988; 14(2-3):181-8. PubMed ID: 3416722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]